会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • PHARMACEUTICAL PREPARATION EFFECTIVE IN AGE-RELATED DISORDERS
    • 药物制剂对与年龄有关的疾病有效
    • WO2017080669A1
    • 2017-05-18
    • PCT/EP2016/001888
    • 2016-11-14
    • ORTHOGEN AG
    • WEHLING, PeterREINECKE, Julio
    • A61K35/14A61K35/16A61P29/00A61P17/00A61P17/18A61P39/00
    • A61K35/14A61K35/16
    • The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an organism, which liquid comprises cellular constituents of blood, providing a vessel or containment means, said vessel or containment means having an internal surface, and contacting said liquid with said vessel or containment means, wherein (a) said production method further comprises the step of incubating said liquid in said vessel or containment means for an incubation time, and optionally removing cellular constituents of said liquid after said incubation, (b) said liquid comprises exosomes, and said production method further comprises the steps of concentrating said exosomes and optionally removing cellular constituents of said liquid after said concentration, or the step of isolating said exosomes, or (c) said production method further comprises the step of avoiding incubation of said liquid, and the step of removing cellular constituents of said liquid contacted with said vessel or containment means.
    • 本发明提供通过注射到皮肤中使用的药物制剂,其中所述药物制剂可通过包括以下步骤的生产方法制备:提供从生物体收集的液体,所述液体包含细胞组分 (a)所述生产方法还包括在所述容器中培养所述液体的步骤,或者(b)所述容器或容器装置具有内表面, (b)所述液体包含外泌体,并且所述生产方法还包括以下步骤:浓缩所述外泌体并任选地在所述浓缩后除去所述液体的细胞组分 或分离所述外泌体的步骤,或(c)所述生产方法进一步c 包括避免所述液体温育的步骤,以及除去与所述容器或容器装置接触的所述液体的细胞组分的步骤。
    • 10. 发明申请
    • COMBINATION THERAPY USING A BLOOD PREPARATION AND A HELMINTHIC PREPARATION
    • 使用血液制备和有用的制剂的组合疗法
    • WO2018036657A1
    • 2018-03-01
    • PCT/EP2017/001010
    • 2017-08-25
    • ORTHOGEN AG
    • WEHLING, PeterREINECKE, Julio
    • A61K35/14A61K35/62A61P19/00
    • A61K35/62A61K35/14A61P19/00A61P19/02A61K2300/00
    • The present invention relates to a combination of a blood preparation and a helminthic preparation for use as a medicament, wherein the blood preparation is preparable by a production method comprising the following steps: providing a blood sample collected from an organism and a vessel or container, contacting said blood sample with said vessel or a container, and incubating said blood sample in said vessel or container, wherein said blood sample is (1) a whole blood sample or (2) a whole blood sample from which certain or all cells have been depleted. Moreover, the present invention relates to the non-therapeutic use of a blood preparation in combination with a helminthic preparation, wherein the helminthic preparation comprises helminths which are incapable of reproducing in the organism and/or which do not infect the organism and particularly do not chronically infect the organism, and wherein the blood preparation is preparable by a production method as described above. In addition, the present invention relates to a kit for use as a medicament or for improving a human's quality of life, wherein the kit comprises a blood preparation and a helminthic preparation, wherein the blood preparation is preparable by a production method as described above.
    • 本发明涉及用作药物的血液制剂和蠕虫制剂的组合,其中所述血液制剂可通过包括以下步骤的制备方法制备:提供从 生物体和容器或容器,使所述血液样品与所述容器或容器接触,并将所述血液样品在所述容器或容器中孵育,其中所述血液样品是(1)全血样品或(2)全血样品 某些细胞或全部细胞已经从中消失。 此外,本发明涉及血液制剂与蠕虫制剂组合的非治疗用途,其中蠕虫制剂包含不能在生物体中繁殖和/或不感染生物体的蠕虫,特别是不能感染生物体 长期感染生物体,并且其中血液制剂可通过如上所述的生产方法制备。 此外,本发明涉及用作药物或改善人类生活质量的试剂盒,其中所述试剂盒包含血液制剂和蠕虫制剂,其中所述血液制剂可通过如上所述的制备方法制备。